INVESTOR
RELATIONS
INVESTOR
RELATIONS
2026.02.12
Financial Reports
Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2026 (Nine Months Ended December 31, 2025)
2025.12.26
Timely Disclosure
Notice of Change in Representative Director of the Subsidiary
2025.12.17
Timely Disclosure
COPD Program of the City of Takamatsu Wins Excellence Award at the 14th Live a Longer Healthy Life Awards – Data analysis assistance helps raise use of checkups and treatments while lowering healthcare expenses –
2025.12.15
Timely Disclosure
ESOP Participation Up 33% over 18 Months as JAST Supports Employee Savings as Inflation Continues
2025.12.10
Financial Results Briefing Materials
FY2026.3 Financial Results Briefing for the 2nd Quarter
2026.02.12
Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2026 (Nine Months Ended December 31, 2025)
2025.11.12
Summary of Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2026 (Six Months Ended September 30, 2025)
2025.08.13
Summary of Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2026 (Three Months Ended June 30, 2025)
2025.12.26
Notice of Change in Representative Director of the Subsidiary
2025.12.17
COPD Program of the City of Takamatsu Wins Excellence Award at the 14th Live a Longer Healthy Life Awards – Data analysis assistance helps raise use of checkups and treatments while lowering healthcare expenses –
2025.12.15
ESOP Participation Up 33% over 18 Months as JAST Supports Employee Savings as Inflation Continues